According to the 2025 China Medical Tourism Development Report, China’s mainland admitted 413,000 overseas patients in 2025 — a year-on-year increase of 63%.
413kOverseas patients in 2025
+63%Year-on-year growth
72hTypical oncology start time
Why are so many patients choosing China? Three reasons stand out: cost, speed, and clinical capability.
Meaningful Cost Savings
Let’s start with costs. The gap between Western private care and top-tier Chinese hospitals is often dramatic — without trading away clinical quality.
Coronary bypass
United States ≈ USD 200,000
Top Chinese hospital ≈ RMB 150,000–200,000
Less than half the US figure
Private gastroscopy
United Kingdom ≈ GBP 3,000–5,000
Chinese public hospital ≈ RMB 2,800 (~GBP 300)
Roughly one-tenth of UK private pricing
Speed That Changes Outcomes
Efficiency is equally striking. 78% of international oncology patients can start treatment within 72 hours of arriving at a Chinese hospital, whereas the average waiting time in their home countries is often over eight weeks.
Clinical Strength, Not Just Affordability
China’s top hospitals have earned international recognition for their clinical and research capabilities. In short, China’s healthcare system is not only affordable — it is also technically advanced.
This is not about cheapness at the expense of quality; it is about genuine value.